1-3 of 3
Mercedes Garayoa, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Filanesib (ARRY-520) Demonstrates Potent and Rapid Activity in Preclinical Models of MM, Dependent on Bcl-2 Family Expression, and Synergistic with Dexamethasone and IMiDs

Susana Hernández-García, Laura San-Segundo, Lorena González-Méndez, Teresa Paíno, PhD, Ana Alicia López-Iglesias, MD, Montserrat Martín-Sánchez, Mercedes Garayoa, PhD BS, Michael J Humphries, PhD, Brian Tunquist, PhD BS, Maria-Victoria Mateos, Enrique M Ocio, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4710.
https://doi.org/10.1182/blood.V124.21.4710.4710
Published: 2014
Journal Articles

The Alkylating Histone Deacetylase Inhibitor Fusion Molecule Edo-S101 Displays Full Bi-Functional Properties in Preclinical Models of Hematological Malignancies

Ana Alicia López-Iglesias, MD, Laura San-Segundo, Lorena González-Méndez, Susana Hernández-García, Daniel Primo, PhD, Mercedes Garayoa, PhD BS, Ana Belén Hernández, PhD, Teresa Paíno, PhD, Maria-Victoria Mateos, MD PhD, Yi Chen, Enrique M. Ocio, MD PhD, Thomas Mehrling, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2100.
https://doi.org/10.1182/blood.V124.21.2100.2100
Published: 2014
Journal Articles

The IGF1-R Inhibitor AEW541 Is a Potent Anti-Myeloma Agent That Overcomes Drugs Resistance, and Has Synergistic Activity with Other New Drugs.

Patricia Maiso, Enrique M. Ocio, MD,PhD, Mercedes Garayoa, PhD, Mark A. Pearson, MD,PhD, Atanasio Pandiella, MD,PhD, J.F. San Miguel, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2599.
https://doi.org/10.1182/blood.V108.11.2599.2599
Published: 2006